A carregar...
Vitamin K antagonists versus low‐molecular‐weight heparin for the long term treatment of symptomatic venous thromboembolism
BACKGROUND: People with venous thromboembolism (VTE) generally are treated for five days with intravenous unfractionated heparin or subcutaneous low‐molecular‐weight heparin (LMWH), followed by three months of vitamin K antagonists (VKAs). Treatment with VKAs requires regular laboratory measurements...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2017
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483166/ https://ncbi.nlm.nih.gov/pubmed/28737834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD002001.pub3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|